49 employees
Ervaxx is illuminating the immune interface to develop new cancer therapies.
2016
$18M
from 2 investors over 2 rounds
Enara Bio raised $18M on November 6, 2019
Investors: SV Life Sciences
Enara Bio raised undisclosed on December 1, 2018
Investors: RA Capital Management, L.P.